Kenya’s pharmaceutical import trends over four years reveal sharp fluctuations in spending.
In 2022, the country spent Sh74.82 billion on pharmaceutical imports, a figure that dropped significantly to Sh52.97 billion in 2023. This decline marked a notable contraction in external pharmaceutical procurement, possibly reflecting policy shifts, supply chain adjustments, or increased local production.
However, the dip was short-lived. In 2024, import spending surged to Sh79.58 billion, the highest in the four-year span. This rebound suggests renewed demand or supply constraints that necessitated higher import volumes. The spike may also reflect global pricing shifts or increased health sector needs.
By 2025, covering only January to September, Kenya had already spent Sh62.06 billion on pharmaceutical imports. Although this figure represents a 22% reduction compared to the same period in 2024, it still indicates a strong reliance on external pharmaceutical supplies.
The drop may be linked to budgetary tightening, improved domestic sourcing, or strategic procurement changes.
The data underscores Kenya’s vulnerability to global pharmaceutical markets and the importance of balancing import reliance with local capacity.
Comments 0
Sign in to join the conversation
Sign In Create AccountNo comments yet. Be the first to share your thoughts!